There is evidence from the HOPE study that the presence of albuminuria indicates increased risk for myocardial infarction, stroke, cardiovascular death, congestive heart failure, and all-cause mortality.
Summary results:
outcomes at median 4.5 years  | with microalbuminuria  | without microalbuminuriaa  | adjusted RR (95% CI)  | 
major cardiovascular events  | 23%  | 14%  | 1.83 (1.64-2.05)  | 
all-cause mortality  | 18%  | 9%  | 2.09 (1.84-2.38)  | 
CHF hospital admission  | 6%  | 2%  | 3.23 (2.54-4.10)  | 
Authors of the study point out that many cardiovascular risk factors are associated with microalbuminuria, including smoking, hypertension, dyslipidaemia, hyperhomocystinemia, dietary protein, and markers of acute phase response. There is a need for further research to clearly assess the independent cardiovascular risk that occurs as a result of the presence (and degree) of albuminuria.
Glomerular Filtration and microalbuminuria:
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.